Total Funding
73
29
Total FundingSeed raised
Growth Score 73 in past quarter
-6 pts
Heat Score 29 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
60781
Cantai Therapeutics operates as a developer of drug candidates.
- Annegret Aa: CEO & Executive DirectorPast Role: Ermium Therapeutics, CSO & CDO
About the Company
Cantai Therapeutics operates as a developer of drug candidates.